
Study shows monoclonal antibody reduces RSV cases in infants by over 80 per cent
A study published in The Lancet Child and Adolescent Health journal discussed the efficiency of a monoclonal antibody administered in infants to reduce respiratory syncytial virus (RSV) cases. According to WHO, each year RSV causes over 3.6 million …